Related by context. All words. (Click for frequent words.) 66 Carotid Revascularization Endarterectomy vs. 66 prospective nonrandomized 65 Edge STudy 65 Screening Trial DMIST 65 number NCT# ClinicalTrials.gov 64 Patient Registry 64 TAXUS ARRIVE 64 retrospective cohort 64 Digital Mammographic Imaging 63 Risk Stratification 63 retrospectively analyzed 63 observational cohort study 63 HE4 test 63 Dr. Kandzari 63 QOPI 63 Fractional Flow Reserve 63 deCODE AF TM 63 prospective longitudinal 63 ILLUSTRATE 63 Corus CAD 63 retrospective cohort study 63 MAGE A3 ASCI 63 DF HCC 62 conducted retrospective cohort 62 EC Cysteamine 62 genomic biomarker 62 LHRH receptor positive 62 multicenter prospective 62 transcranial Doppler ultrasound 62 clinico pathological 62 pain palliation 62 differentiate squamous 62 HDL Selective Delipidation 62 FFR measurements 62 tumor histology 62 Accessed #/#/# [001] 62 CINQUIL 62 ADHERE 62 patientswith 62 deCODE ProstateCancer TM 62 PLAC test 62 microRNA profiling 62 HPV genotyping 62 Val HeFT 62 phase IIIb 62 multicentre prospective 62 EECP ® therapy 62 Asthma Intervention 61 multivessel coronary artery 61 Single Molecule Array SiMoA 61 prospective multicentre 61 BioMAP 61 longitudinal cohort study 61 cardiac perfusion 61 genetic biomarkers 61 AFRS TM 61 gefitinib Iressa 61 OvaRex MAb 61 genomewide 61 hyaluronidase enzyme 61 Prostate Px + 61 PREVU * LT 61 perfusion CT 61 NuroPro PD 61 DNA methylation biomarker 61 metabonomics 61 Accelerated Partial Breast Irradiation 61 neratinib 61 multicenter randomized controlled 61 AQUA ® 61 clinicopathological 61 Acute Decompensated Heart Failure 61 Vascugel ® 61 pharmacogenetic testing 61 NCIC CTG 61 undergone radical prostatectomy 61 CARE HF 61 RE LY 61 CHARISMA trial 60 novel oral anticoagulant 60 ICAEL 60 Prostate Disease 60 genotype phenotype 60 Intervention Effectiveness 60 Thomson Reuters MarketScan 60 zoledronic acid Reclast 60 Teriflunomide 60 experimental therapeutics 60 genomic profiling 60 therapeutic radiopharmaceuticals 60 prospective multicenter 60 Oncotype 60 metaanalysis 60 Elena Losina 60 Vertos II 60 FDG PET imaging 60 pregabalin Lyrica 60 ExTRACT TIMI 60 Endovascular Valve Edge 60 basal bolus regimen 60 diagnosing coronary artery 60 #:#-# [024] 60 near infrared spectroscopic 60 DNAwithPap TM Test 60 TriGrid 60 kidney urologic 60 REALITY Trial 60 Multivariate logistic regression 60 ADVEXIN therapy 60 Diabetic Foot Ulcer 60 Current Controlled Trials 60 diagnose coronary artery 60 Affymetrix microarray technology 60 angiographically 60 recurrent metastatic 60 OGAP R 60 randomized controlled multicenter 60 Pyridorin 60 transrectal ultrasound guided 60 multicenter randomized clinical 60 cerebral oximetry 60 HEDIS R 60 Clinical Antipsychotic Trials 60 Perforomist ™ Inhalation Solution 60 acadesine 60 miRNA biomarkers 60 LungSign TM 60 prognostic indicators 60 NSABP B 60 AF Suppression 60 thalidomide Thalomid 60 Phase III multicenter 60 antiretroviral naïve 60 V3D Colon 60 hemangioblast 60 meta regression 60 BR.# 60 ZACTIMA 60 prospective multicenter study 59 GAMMAGARD 59 Deforolimus 59 BEZ# 59 Temsirolimus 59 underwent coronary angiography 59 CALGB 59 ONTARGET 59 stratifying patients 59 Resolute stent 59 clevidipine 59 retrospective observational study 59 ImmuKnow R 59 Caris MPI 59 diagnostic biomarker 59 ACRIN 59 prelicensure 59 Clinicaltrials.gov 59 commercialize deforolimus 59 PROactive study 59 metastatic neuroendocrine tumors 59 biochemical profiling 59 Unstable Angina 59 ovarian endometrial 59 STEP BD 59 prognostic biomarker 59 Sentinel Lymph Node Biopsy 59 CareManager 59 OMAPRO ™ 59 LungAlert TM 59 congenital toxoplasmosis 59 NMR LipoProfile 59 exemestane Aromasin 59 orally inhaled migraine 59 VerifyNow P#Y# 59 Maven Semantic 59 placebo controlled dose escalation 59 genitourinary cancers 59 noninvasive outpatient 59 radiolabeled TM# 59 biostatistical analysis 59 Cardiotoxicity 59 eTag assays 59 pretransplant 59 CGEMS 59 Intravenous immunoglobulin 59 Axial Biotech 59 CHAMPION PCI 59 acyclovir Lauriad R 59 observational cohort 59 Left Ventricular Dysfunction 59 longitudinal cohort 59 ASTEROID 59 descending thoracic 59 evaluating Actimmune 59 Bionate ® PCU 59 conditional logistic regression 59 Renal Artery 59 Outcome Sciences 59 manually curated 59 Braunwald 59 BRIM3 59 COR Analyzer 59 GLOBOCAN 59 Medidata Designer 59 STRIDE PD 59 miRview ™ squamous 59 Warfarin Coumadin 59 galiximab 59 Vidaza azacitidine 59 Histopathological 59 PREVENT IV 59 vitespen 59 ACC NCDR 59 AVONEX PEN 59 Group RTOG 59 pelvic malignancies 59 Septin9 59 human IgG1 monoclonal 59 TNM staging 59 prospective observational studies 59 Bayer HealthCare Onyx Pharmaceuticals 59 microarray gene expression 59 immunochemical fecal occult 59 venous thromboembolic disease 59 ADVIA Centaur 59 mutated K ras 59 HuMax Wnt 59 Monogram Trofile Assay 59 CYP#D# inhibitor 59 multivariate Cox 59 diagnostic prognostic 59 Multiple logistic regression 59 thetreatment 59 VerifyNow 59 carotid artery stenting CAS 59 REMINYL ® 58 LungCAD 58 BACcel 58 Trandolapril 58 Aureon 58 physicians podiatrists 58 Echocardiographic 58 VeraCode 58 acetabular fractures 58 PK PD modeling 58 Mammostrat 58 alpha1 antitrypsin deficiency 58 placebo controlled clinical 58 multimodality imaging 58 Prospective Randomized 58 DNA methylation markers 58 ASSERT 58 LUMINATE 58 immunotherapeutic vaccine 58 Rheos System 58 IDI MRSA 58 haematologic 58 neuropsychological assessments 58 HIV coinfected 58 Immune Tolerance Network 58 resectable pancreatic cancer 58 Skin sterol 58 Stretta System 58 ZOLINZA 58 Abbott ARCHITECT 58 Screening Trial 58 Abdominal ultrasound 58 VeriStrat 58 PROLARIS 58 DAPT Study 58 PLX STROKE targeting 58 GEMS TM 58 EGIR 58 thrombophilia 58 Buhimschi 58 peptide conjugated 58 epoetin alpha 58 GeneSightRx 58 LAB CGRP 58 R nonlinear algorithm 58 kinase profiling 58 Gynecologic Oncology Group 58 preclinical efficacy 58 relapsing multiple sclerosis 58 Xelox 58 refractory metastatic 58 Cardio3KG 58 trastuzumab DM1 T DM1 58 Spectranetics laser 58 HCUP 58 Meta analyzes 58 SORT OUT III 58 bisulfite sequencing 58 quantitative gene expression 58 Intervention Effectiveness CATIE 58 antiphospholipid antibodies 58 GENASIS 58 reslizumab 58 Ultrasonographic 58 Viatronix V3D Colon 58 pharmacogenetic tests 58 Clinical Trials Consortium 58 Scripps Genomic Medicine 58 Degarelix 58 PEGylated interferon 58 KN excels 58 SIMPADICO 58 FDG PET scans 58 retrospective observational 58 double blinded randomized 58 diagnostic modality 58 ICD Registry 58 EarlyCDT Lung 58 Phase IIb III 58 Zemplar Capsules 58 immunohistochemical analysis 58 Psynova 58 RESOLUTE clinical 58 NMES 58 REPLACE Registry 58 logistic regression analysis 58 TRIST study 58 Quinamed 58 targeted radiotherapeutic 58 PD2i ® 58 Bucindolol 58 PreDx 58 Translational Science Award 58 QRISK 58 comparative genomic hybridization 58 Trofex 58 Vitrea ® 58 Ophena 58 Acute Stroke 58 NPWH 58 randomized discontinuation 58 Inhaled nitric oxide 58 Renal Cell Carcinoma RCC 58 Cancer Incidence Mortality 58 vinca alkaloid 58 Quantitative PCR 58 Medicsight ColonCAD 58 GeneGo MetaCore 58 recurrent malignant glioma 58 recurrent bladder 58 IMiDs ® compound 58 multiple logistic regression 58 CYT# potent vascular disrupting 58 Lucanix 58 SWOG 58 DFCI 58 duplex ultrasonography 58 diabetes mellitus DM 58 CALGB # [002] 58 Optical Coherence Tomography 58 SYNTAX trial 58 Surgical resection 58 MammaPrint ® 58 mild hepatic impairment 58 Alternans 58 deCODE BreastCancer 58 ClinicalTrials.gov 58 Lewy bodies DLB 58 ImmuKnow assay 58 catheter ablations 58 HepDirect prodrug 58 pharmacologic therapies 58 Functional neuroimaging 58 obstructive coronary artery 58 Pertuzumab 58 Vasomedical enhanced 58 HepaMate 58 CA9 SCAN 58 Myocardial Perfusion Imaging 58 Dr. Gabriel Lasala 58 ALTROPANE 58 ALTTO 58 Randomized controlled 58 gynecologic procedures 58 OnDose 58 intraobserver 58 CT colonography CTC 58 National Oncologic PET 58 BCIRG 58 Cytogenetic 58 Platinol ® cisplatin 58 Syllego system 58 budesonide MMX Phase III 57 metastatic pancreatic 57 corticosteroid induced 57 EmbraceAC 57 Endovascular System 57 prospective randomized multicenter 57 treat brain aneurysms 57 oral squamous cell 57 PARTNER Trial 57 HER2 overexpression 57 Stenting Trial CREST 57 Cardiolite ® 57 offers deCODE T2 57 confirmatory clinical 57 abnormal cytology 57 MGd 57 HPCGG 57 visit http:/www.clinicaltrials.gov/ 57 non nucleoside 57 pharmacokinetic pharmacodynamic 57 Afatinib 57 NCT# ClinicalTrials.gov 57 KL4 Surfactant 57 Modrenal 57 UroVysion 57 OZURDEX 57 prostate cancer PCa 57 microbiologically evaluable 57 Zestra R 57 occipital nerve stimulation 57 everolimus eluting stents 57 Rilonacept 57 Alequel 57 genomewide association study 57 TARGIT 57 blinded randomized controlled 57 AVERROES 57 ticagrelor Brilinta 57 Amelior ED R 57 FullTerm 57 Neuromuscular Disorders 57 RE LY ® 57 transabdominal 57 NSCLC tumors 57 cytogenic 57 thoracoscopic lobectomy 57 BEXXAR Therapeutic Regimen 57 humanised antibody 57 Epi LASIK 57 autologous cultured chondrocytes 57 Pharmacogenetic 57 MammaPrint R 57 relapsed MM 57 Complications Trial 57 Vizilite 57 Proellex TM 57 Reynolds Risk Score 57 guideline concordant 57 ovarian pancreatic 57 biomarker assays 57 Electronic Brachytherapy 57 Pediatric Rheumatology 57 pretreatment serum 57 sorafenib Nexavar 57 Raloxifene STAR 57 Peer Reviewed Medical 57 relapsed ALL 57 Phase #b/#a clinical 57 HF ACTION 57 transcatheter aortic valve implantation 57 Estrogen Receptor 57 Pharmacoeconomic 57 MelaFind pivotal 57 NMR LipoProfile test 57 laser Doppler 57 Pre implantation genetic 57 multicenter Phase II 57 bioengineered tissue 57 AtherOx 57 bone scintigraphy 57 colorectal adenoma 57 unstable angina UA 57 BrainGate TM 57 Evaluation WISE 57 proteomic biomarkers 57 SF #v# 57 esophagogastric 57 functional neuroimaging 57 metastatic lymph nodes 57 Poisson regression 57 coronary computed tomography 57 prognostic variables 57 Common Toxicity Criteria 57 Epigenomics proprietary 57 Genedata Expressionist ® 57 HuMax 57 Dana-Farber/Children s Hospital 57 MADIT II 57 Observational Study 57 OHRI 57 nonmetastatic 57 WallFlex Biliary RX 57 Multicenter Automatic Defibrillator Implantation 57 intracranial stenosis 57 pharmacologic stress 57 RemedyMD 57 therapeutic monoclonal antibody 57 ACCORD Lipid 57 assessing T DM1 57 CellSearch System 57 evaluating tivozanib 57 Montalescot 57 randomized blinded 57 Hypertriglyceridemia 57 DSM IV diagnoses 57 HeartNet 57 fosbretabulin 57 postoperative radiotherapy 57 PD2i 57 Sipuleucel T 57 recurrent glioblastoma multiforme 57 delipidation 57 CT pulmonary angiography 57 ToGA 57 Mendelian randomization 57 VADT 57 NCCN Compendium 57 Cholesterol Levels SPARCL 57 BREVAGen ™ 57 XIENCE V Everolimus Eluting 57 NADiA 57 RE LY trial 57 murine models 57 Zevalin consolidation 57 Hodgkin lymphoma HL 57 Li Fraumeni 57 NATRECOR ® 57 undergo prostate biopsy 57 ACUITY trial 57 cerebral microbleeds 57 lexidronam injection 57 molecular diagnostic assays 57 etiologic 57 Phase 1a clinical 57 CIMZIA TM certolizumab pegol 57 MYTHOS trial 57 SIX RO ROG 57 ROCHESTER Minn. Mayo Clinic 57 SEER database 57 tumor subtype 57 florbetaben 57 Insulin Resistance Atherosclerosis 57 skin sterol 57 PECARN 57 histologically proven 57 Current Author Addresses 57 SiDMAP 57 Kathy Giusti myeloma 57 PressureWire Certus 57 EchoCRT 57 NMIBC 57 ChronVac C R 57 multivariable Cox 57 Bellicum 57 PROMUS TM 57 biomarker identification 57 endometriosis ovarian cysts 57 pharmacodynamic markers 57 randomized Phase IIb 57 Safinamide 57 metastatic gastric 57 PI3K/Akt pathway inhibitor 57 Multidetector CT 57 Vidaza ® 57 QuadraSphere 57 MD MHSc 57 Novo TTF 57 relapsing remitting MS RRMS 57 PORxin TM 57 adjunctively 57 prospective observational cohort 57 OnDose TM 57 Afib 57 Hertzel Gerstein 57 endoscopic ultrasound 57 rEEG 57 Cloretazine 57 GEM OS2 57 HealthCore 57 metabolomics driven 57 CareEngine ® System 57 ASCUS 57 SpectraCell 57 multivariate logistic regression 57 pharmacogenomic translational research 57 microdissection 57 Logistic regression 57 pharmacokinetic PK study 57 interstitial brachytherapy 57 drotrecogin alfa activated 57 EndoTAGTM 1 57 superparamagnetic iron oxide nanoparticles 57 ONCONASE R 57 beta carotene supplementation 57 BioSET 57 MedPulser 57 RE MODEL 57 selective estrogen receptor modulator 57 ICON7 57 BioZ ICG 57 substudy 57 Monoclonal antibody 57 immunomodulatory agents 57 HORIZONS AMI 57 immunohistochemical 57 Lumbar Interbody Fusion 57 Cornea Donor Study 56 pharmacodynamic PD 56 Lymph node 56 Spartan RX CYP#C# 56 underwent percutaneous coronary 56 www.ClinicalTrials.gov 56 Prostate Lung Colorectal 56 miRview meso 56 Charlson Comorbidity Index 56 NKI AVL 56 recurrent metastatic ovarian cancer 56 Phase III AFFIRM 56 Advanced Heart Failure 56 GERD migraine headaches 56 prospective observational 56 Selective Electrochemical Tumor Ablation 56 susceptibility loci 56 TMS Therapy 56 Phase III ADT 56 nonpharmacologic 56 papillary renal cell carcinoma 56 HyACT 56 Univariate 56 interventional neuroradiology 56 choroidal vasculopathy 56 oncologic outcomes 56 convergent validity 56 Coronary CTA 56 Vaxfectin TM 56 refractory colorectal cancer 56 nonrandomized 56 please visit www.brighamandwomens.org 56 DNA methylation biomarkers 56 antibiofilm 56 bioprosthetic valve 56 transdermal testosterone 56 BRCA testing 56 Tectin TM 56 gene methylation 56 TASKi3 56 Campath alemtuzumab 56 SensiGene 56 immunotherapeutic approaches 56 univariate 56 sirolimus eluting stents 56 pharmaco 56 IMiDs ® 56 briakinumab 56 stereotactic radiotherapy 56 oral antiplatelet agent 56 VBLOC TM 56 neoadjuvant treatment 56 Western Blotting 56 Matrix Phase 2b 56 gemtuzumab ozogamicin 56 neuro oncologists 56 Common Terminology Criteria 56 Genomic Grade 56 thoracic aortic disease 56 TAXUS VI 56 Ovarian PLCO Cancer 56 ImmunoGen TAP technology 56 NeuroMove TM 56 Erimos 56 acetonide FA 56 PON1 activity 56 #q# deletion 56 Oral NKTR 56 Cardiorespiratory fitness 56 assn.org 56 Wadih Arap 56 genotypic resistance 56 Prosaptide 56 Panzem NCD 56 Registry NOPR 56 cellular immunotherapy 56 Oncomine 56 histological subtype 56 Pediatric Diabetes 56 Virtual Histology 56 radioimmunotherapy RIT 56 somatostatin analog 56 PROMUS R 56 dbGaP 56 Veronate R 56 Intervention Trial GAIT 56 Med eXpert 56 polyarticular 56 OncotypeDX 56 logistic regression models 56 Kahalalide F 56 molecular cytogenetic 56 randomized controlled trials RCTs 56 Magnetic resonance 56 Appropriateness Criteria 56 prospectively stratified 56 Thrombolysis 56 NSABP 56 #-# Full Text 56 cyclophilin inhibitors 56 postmarketing adverse 56 MetaDrug TM 56 EBUS FNA 56 Kinesia 56 ER CHOP 56 Phase III VISTA 56 EDEMA3 trial 56 Plaquenil 56 VERICIS 56 de novo AML 56 FDG-PET/CT 56 Aggressive Drug Evaluation 56 anti arrhythmic 56 PFO migraine 56 Raloxifene Evaluation MORE 56 Coronary angiography 56 Angiographic 56 indications contraindications 56 NPC 1C 56 KRAS gene mutations 56 AFREZZA TM 56 urodynamic 56 immunochemical 56 hematopoietic cancers 56 Electroencephalography 56 coexisting illnesses 56 DXA scan 56 generalized estimating 56 REVIVE Diabetes 56 Mantel Haenszel 56 BARI 2D 56 endocrinologic 56 pharmacokinetic PK 56 multicenter clinical trials 56 PhysioLab 56 electrodiagnostic 56 Balloon sinuplasty 56 produces radioisotopes 56 PressureWire 56 multicenter multinational 56 HORIZONS AMI trial 56 ID NCT# 56 NAEPP 56 artery embolization 56 NEVO RES 56 GBA mutations 56 Quantitative EEG 56 J Am Coll 56 colorectal liver metastases 56 Triapine 56 multicenter phase 56 Limperopoulos 56 laparoscopic radical nephrectomy 56 urothelial cancer 56 systemic RNAi therapeutic 56 Hemoccult II 56 busulfan 56 predictive biomarker 56 molecular biomarkers 56 von Willebrand Disease 56 Refractory Angina 56 pertuzumab 56 electrocardiography ECG 56 CALM Shoulder Screen 56 Practice Patterns 56 NAVISTAR R 56 Resurgex Plus 56 PROTEGE 56 balloon brachytherapy 56 candidate TNFerade biologic 56 Vocada Veriphy 56 Amy Abernethy 56 diagnosing ADHD 56 multivariable analysis 56 PORxin TM platforms 56 OvaDx 56 AviaraDx 56 Order Optimizer 56 ADMIRE HF 56 CupPrint 56 NCT# 56 INS# [001] 56 Signal X6 56 Cielo Clinic 56 abacavir Ziagen 56 Coronary Artery Bypass Graft 56 perimetry 56 ReN# 56 Polysomnography 56 opioid naive 56 Hyperbaric Oxygen Therapy HBOT 56 gene expression microarrays 56 coronary stent merged 56 thorough QT 56 Initiate Clinical Trial 56 convulsive disorders 56 eligen 56 nucleotide analogue 56 etanercept Enbrel 56 MADIT 56 CyPath ® 56 SJTRI 56 hip resurfacing arthroplasty 56 Dural Sealant 56 TransVax tm 56 USA UroToday.com 56 Impac Software 56 CIN2 + 56 EVEREST II 56 APTIMA HPV 56 Pemphigus 56 juvenile idiopathic arthritis 56 NIR spectroscopy 56 GVAX Pancreas Vaccine 56 Yukon Government Minfile 56 STENT 56 metabolomic profiling 56 multi analyte 56 Pediatric Oncology Branch 56 fusion enhancers 56 clinically validated 56 ImmunoCAP ® 56 tubulin inhibitor 56 REVEAL Registry 56 CT angiography CTA 56 multivariate analyzes 56 cytomegalovirus infection 56 NCCTG 56 staphylococcal vaccine 56 novel therapeutic antibodies 56 unresectable tumors 56 Aflibercept 56 ospemifene 56 targeted anticancer therapies 56 predictive toxicology 56 Rosetta Genomics microRNA 56 NHAMCS 56 HG PIN 56 MGMT methylation 56 please visit www.metabolon.com 56 CytoSure 56 Illumina Solexa 56 multicentre randomized 56 National Emphysema Treatment 56 Comorbidity 56 LipiScan 56 BioMAP ® 56 APPRAISE 56 aMCI precursor 56 International Verapamil SR 56 Principle Investigator 56 randomized multicenter trial 56 Diagnostic Tests 56 OHSU Doernbecher 56 NAMCS 56 GI motility disorders 56 OpenNotes 56 allogeneic HSCT 56 Coronary Angiography 56 SEER registry 56 EDEMA3 56 GeneSearch 56 comorbid anxiety 56 ACOSOG Z# 56 EQ 5D 56 ImmuKnow 56 visceral metastases 56 TNFerade TM 56 glucocorticoid induced osteoporosis 56 Intravesical 56 Hepatocellular Carcinoma HCC 56 underwent radical prostatectomy 56 DCA Vantage 56 anatomic pathology laboratory 56 AIM HIGH 56 Hepsera adefovir dipivoxil 56 Septin 9 56 INSPIRE Trial Phase III 56 thoracic surgical 56 BRIM2 56 antiangiogenic agent 56 bifurcation stent 56 MIST II 56 transesophageal echocardiography TEE 56 prostate cancer CaP 56 humanised monoclonal antibody 56 SEER registries 56 Subgroup analysis 56 topically applied SEPA 56 Nanotechnology Characterization Laboratory 56 PF # [002] 56 QEEG 56 Fc gamma receptor 56 interventional neuroradiologists 56 Sirolimus eluting 56 demonstrated antitumor activity 56 psoriasis Crohn disease 55 GliaSite 55 Capesaris 55 Cervista HPV HR 55 qNPA 55 HALO# [002] 55 Prostate Cancer Prevention 55 coronary CTA 55 radionuclide imaging 55 predictive biomarkers 55 validate biomarkers 55 prospectively evaluated 55 carotid artery stenting 55 core needle biopsies 55 OLYMPIA registry 55 PharMetrics 55 Multicentre 55 prostate carcinogenesis 55 Tomophase 55 Pharmaprojects 55 Multicenter AIDS 55 AVOREN 55 EnRhythm MRI SureScan pacing 55 bortezomib Velcade 55 Ortho Dermatologics 55 TransMID 55 Peripheral Arterial 55 FIX HF 5 55 discontinued Viread 55 postapproval 55 CeaProve R 55 miRview mets 55 LentiVector 55 registrational Phase 55 electrophysiologic 55 pancreatic adenocarcinoma 55 SUTENT ® 55 DECIPHER 55 Vascular Disease Foundation 55 multiparametric 55 electrophysiology EP 55 diagnostic angiography 55 TransVax ™ 55 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 55 Pegloticase 55 invasive lobular carcinoma 55 PRoFESS 55 DynaMed 55 LEAPS TM 55 CellSearch ™ 55 NSQIP 55 Emboshield 55 functional mitral regurgitation 55 MDCT angiography 55 NexCura 55 Aplidin 55 MVA MUC1 IL2 55 PreDx DRS 55 Zenvia Phase III 55 ezetimibe simvastatin 55 Fetal Fibronectin Test 55 chronic thromboembolic pulmonary 55 non resectable metastatic 55 multivariate statistical 55 miRview ™ mets 55 Depressed bipolar 55 ePREOP 55 Cytoxan ® 55 molecular biomarker 55 ACCULINK 55 inferential statistics 55 KRAS mutation 55 SELDI TOF MS 55 urologic pathology 55 metabolomic profiles 55 BRAF inhibitor 55 Genotypic 55 enzyme immunoassay EIA 55 ThermoDox ® clinical 55 Sorafenib Nexavar 55 MDRD equation 55 Diabetic Neuropathy 55 NICE SUGAR 55 miglustat 55 methylation markers 55 VerifyNow System 55 Acute Coronary Syndromes ACS 55 HuMax EGFr 55 magnetic resonance spectroscopy MRS 55 See CLINICAL PHARMACOLOGY 55 euglycemic clamp 55 REG1 55 sunitinib malate 55 clinicopathologic 55 CHADS2 55 miRNA profiling 55 osteopathic manipulative treatment 55 Patricia Hartge 55 serum biomarker 55 metastatic malignant 55 TSQ Quantum